Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A four-year-old girl from northern Italy has died of cerebral malaria, it was recently announced. The case is puzzling Italian healthcare officials as the country was declared malaria free in 1970, and the girl, Sofia Zago, had not been abroad.

The Conversation logo

Although Italy was one of the most endemic European countries for malaria during the 20th century – until DDT was used to eradicate it – the scientific puzzle shrouding the girl’s death is the fact that it was caused by Plasmodium falciparum, which is mainly found in Africa. The likelihood that an Italian mosquito transmitted the disease is very small.

In fact, it has been reported that investigators are considering that Zago may have been infected with a re-used needle when she was being treated for her diabetes at Santa Chiara hospital. (A family, who’d recently returned from a trip to Africa, were being treated for malaria at the same hospital.) However, this is still speculation.

 

Read more....

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.